Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

Summary

The purpose of this study is to look at a subset of plexiform neurofibromas and determine if the airway tumors are more sensitive to imatinib therapy. Funding Source - FDA OOPD

Timeline

Start

2018-09-01

Primary completion

2020-09-01

Completion

2021-09-01

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment not feasible”

Drugs

Indications